Average starting option 10 mg Available options 10 mg 20 mg 30 mg 40 mg Provider note: Do not change dose, frequency, or route of use unless directed by your clinician
The absence of a known interaction in databases means that direct, significant interactions have not been documented
It can be stopped abruptly without causing withdrawal or harm
Ueki K, Kondo T, Kahn CR
El papel de los especialistas no solo recae en recetar, sino tambin en educar y acompaar durante el proceso, ajustando estrategias segn el perfil y evolucin de cada persona
GLP-1 receptor agonists exert neuroprotective effects primarily by inhibiting microglial activation, the primary effector cells of neuroinflammation, thus reducing the production of proinflammatory cytokines (e.g., TNF- , IL-1) and alleviating inflammatory damage to brain parenchyma